Cancer related fatigue: A focus on breast cancer and Hodgkin's disease survivors

References

• Wagner LI, Cella D. Fatigue and cancer: Causes, prevalence and treatment approaches. Br J Cancer 2004; 91: 822–8
   PubMed Web of Science ®Google Scholar
• Ganz PA, Moinpour CM, Pauler DK, Kornblith AB, Gaynor ER, Balcerzak SP, et al. Health status and quality of life in patients with early-stage Hodgkin's disease treated on Southwest Oncology Group Study 9133. J Clin Oncol 2003; 21: 3512–9
   PubMed Web of Science ®Google Scholar
• Dow KH, Ferrell BR, Leigh S, Ly J, Gulasekaram P. An evaluation of the quality of life among long-term survivors of breast cancer. Breast Cancer Res Treat 1996; 39: 261–73
   PubMed Web of Science ®Google Scholar
• Jacobsen PB, Stein K. Is fatigue a long-term side effect of breast cancer treatment?. Cancer Control 1999; 6: 256–63
   PubMedGoogle Scholar
• Bower JE, Ganz PA, Desmond KA, Bernaards C, Rowland JH, Meyerowitz BE, et al. Fatigue in long-term breast carcinoma survivors: A longitudinal investigation. Cancer 2006; 106: 751–8
   PubMed Web of Science ®Google Scholar
• Mitchell SA, Berger AM. Cancer-related fatigue: The evidence base for assessment and management. Cancer J 2006; 12: 374–87
   PubMed Web of Science ®Google Scholar
• Andrykowski MA, Schmidt JE, Salsman JM, Beacham AO, Jacobsen PB. Use of a case definition approach to identify cancer-related fatigue in women undergoing adjuvant therapy for breast cancer. J Clin Oncol 2005; 23: 6613–22
   PubMed Web of Science ®Google Scholar
• Vogelzang NJ, Breitbart W, Cella D, Curt GA, Groopman JE, Horning SJ, et al. Patient, caregiver, and oncologist perceptions of cancer-related fatigue: Results of a tripart assessment survey. The Fatigue Coalition. Semin Hematol 1997; 34(3 Suppl 2)4–12
   PubMed Web of Science ®Google Scholar
• Jacobsen PB. Assessment of fatigue in cancer patients. J Natl Cancer Inst Monographs 2004; 32: 93–7
   Google Scholar
• Sadler IJ, Jacobsen PB. Progress in understanding fatigue associated with breast cancer treatment. Cancer Invest 2001; 19: 723–31
   PubMed Web of Science ®Google Scholar
• Andrykowski MA, Curran SL, Lightner R. Off-treatment fatigue in breast cancer survivors: A controlled comparison. J Behav Med 1998; 21: 1–18
   PubMed Web of Science ®Google Scholar
• Broeckel JA, Jacobsen PB, Horton J, Balducci L, Lyman GH. Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. J Clin Oncol 1998; 16: 1689–96
   PubMed Web of Science ®Google Scholar
• Bower JE, Ganz PA, Desmond KA, Rowland JH, Meyerowitz BE, Belin TR. Fatigue in breast cancer survivors: Occurrence, correlates, and impact on quality of life. J Clin Oncol 2000; 18: 743–53
   PubMed Web of Science ®Google Scholar
• Lindley C, Vasa S, Sawyer WT, Winer EP. Quality of life and preferences for treatment following systemic adjuvant therapy for early-stage breast cancer. J Clin Oncol 1998; 16: 1380–7
   PubMed Web of Science ®Google Scholar
• Servaes P, Verhagen C, Bleijenberg G. Fatigue in cancer patients during and after treatment: Prevalence, correlates and interventions. Eur J Cancer 2002; 38: 27–43
   PubMed Web of Science ®Google Scholar
• Berger AM, Higginbotham P. Correlates of fatigue during and following adjuvant breast cancer chemotherapy: A pilot study. Oncol Nurs Forum 2000; 27: 1443–8
   PubMedGoogle Scholar
• Bower JE, Ganz PA, Aziz N, Fahey JL. Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosom Med 2002; 64: 604–11
   PubMed Web of Science ®Google Scholar
• Smets EM, Visser MR, Willems-Groot AF, Garssen B, Oldenburger F, van Tienhoven G, et al. Fatigue and radiotherapy: (A) experience in patients undergoing treatment. Br J Cancer 1998; 78: 899–906
   PubMed Web of Science ®Google Scholar
• Goldstein D, Bennett B, Friedlander M, Davenport T, Hickie I, Lloyd A. Fatigue states after cancer treatment occur both in association with, and independent of, mood disorder: a longitudinal study. BMC Cancer 2006; 6: 240
   PubMed Web of Science ®Google Scholar
• Fobair P, Hoppe RT, Bloom J, Cox R, Varghese A, Spiegel D. Psychosocial problems among survivors of Hodgkin's disease. J Clin Oncol 1986; 4: 805–14
   PubMed Web of Science ®Google Scholar
• Knobel H, Havard LJ, Brit LM, Forfang K, Nome O, Kaasa S. Late medical complications and fatigue in Hodgkin's disease survivors. J Clin Oncol 2001; 19: 3226–33
   PubMed Web of Science ®Google Scholar
• Loge JH, Abrahamsen AF, Ekeberg O, Kaasa S. Hodgkin's disease survivors more fatigued than the general population. J Clin Oncol 1999; 17: 253–61
   PubMed Web of Science ®Google Scholar
• Loge JH, Abrahamsen AF, Ekeberg Ø, Kaasa S. Fatigue and psychiatric morbidity among Hodgkin's disease survivors. J Pain Symptom Manage 2000; 19: 91–9
   PubMed Web of Science ®Google Scholar
• Greil R, Holzner B, Kemmler G, Kopp M, Buchowski A, Oberaigner W, et al. Retrospective assessment of quality of life and treatment outcome in patients with Hodgkin's disease from 1969 to 1994. Eur J Cancer 1999; 35: 698–706
   PubMed Web of Science ®Google Scholar
• Hjermstad MJ, Fossa SD, Oldervoll L, Holte H, Jacobsen AB, Loge JH. Fatigue in long-term Hodgkin's disease survivors: A follow-up study. J Clin Oncol 2005; 23: 6587–95
   PubMed Web of Science ®Google Scholar
• Hjermstad MJ, Oldervoll L, Fossa SD, Holte H, Jacobsen AB, Loge JH. Quality of life in long-term Hodgkin's disease survivors with chronic fatigue. Eur J Cancer 2006; 42: 327–33
   PubMed Web of Science ®Google Scholar
• Ruffer JU, Flechtner H, Tralls P, Josting A, Sieber M, Lathan B, et al. Fatigue in long-term survivors of Hodgkin‘s lymphoma; a report from the German Hodgkin Lymphoma Study Group (GHSG). Eur J Cancer 2003; 39: 2179–86
   PubMed Web of Science ®Google Scholar
• Ng AK, Li S, Recklitis C, Neuberg D, Chakrabarti S, Silver B, et al. A comparison between long-term survivors of Hodgkin's disease and their siblings on fatigue level and factors predicting for increased fatigue. Ann Oncol 2005; 16: 1949–55
   PubMed Web of Science ®Google Scholar
• Press OW, LeBlanc M, Lichter AS, Grogan TM, Unger JM, Wasserman TH, et al. Phase III randomized intergroup trial of subtotal lymphoid irradiation versus doxorubicin, vinblastine, and subtotal lymphoid irradiation for stage IA to IIA Hodgkin's disease. J Clin Oncol 2001; 19: 4238–44
   PubMed Web of Science ®Google Scholar
• Ganz, PA, Moinpour, CM, McCoy, S, Pauler, DK, Press, OW, Fisher, RI. Predictors of vitality (energy/fatigue) in early stage Hodgkin's disease (HD): Results from Southwest Oncology Group (SWOG) Study 9133. J Clin Oncol 2004;22:6546, (Abstract)
   Web of Science ®Google Scholar
• Adler HL, McCurdy MA, Kattan MW, Timme TL, Scardino PT, Thompson TC. Elevated levels of circulating interleukin-6 and transforming growth factor-beta1 in patients with metastatic prostatic carcinoma. J Urol 1999; 161: 182–7
   PubMed Web of Science ®Google Scholar
• Herskind C, Bamberg M, Rodemann HP. The role of cytokines in the development of normal-tissue reactions after radiotherapy. Strahlenther Onkol 1998; 174(Suppl 3)12–5
   PubMed Web of Science ®Google Scholar
• Dantzer R. Cytokine-induced sickness behavior: Mechanisms and implications. Ann N Y Acad Sci 2001; 933: 222–34
   PubMed Web of Science ®Google Scholar
• Maier SF, Watkins LR. Cytokines for psychologists: Implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychol Rev 1998; 105: 83–107
   PubMed Web of Science ®Google Scholar
• Kurzrock R. The role of cytokines in cancer-related fatigue. Cancer 2001; 92(6 Suppl)1684–8
   PubMed Web of Science ®Google Scholar
• Bower, JE, Ganz, PA, Tao, ML, Fahey, JL. Mechanisms of radiation-induced fatigue: Proinflammatory cytokines and depression. Paper presented at the California Breast Cancer Research Program Symposium. September, 2003, (Abstract).
   Google Scholar
• Greenberg DB, Gray JL, Mannix CM, Eisenthal S, Carey M. Treatment-related fatigue and serum interleukin-1 levels in patients during external beam irradiation for prostate cancer. J Pain Symptom Manage 1993; 8: 196–200
   PubMed Web of Science ®Google Scholar
• Collado-Hidalgo A, Bower JE, Ganz PA, Cole SW, Irwin MR. Inflammatory biomarkers for persistent fatigue in breast cancer survivors. Clin Cancer Res 2006; 12: 2759–66
   PubMed Web of Science ®Google Scholar
• Bower JE, Ganz PA, Aziz N, Fahey JL, Cole SW. T-cell homeostasis in breast cancer survivors with persistent fatigue. JNCI Cancer Spectrum 2003; 95: 1165–8
   Google Scholar
• Bower JE, Ganz PA, Dickerson SS, Petersen L, Aziz N, Fahey JL. Diurnal cortisol rhythm and fatigue in breast cancer survivors. Psychoneuroendocrinology 2005; 30: 92–100
   PubMed Web of Science ®Google Scholar
• Bower, JE, Ganz, PA, Aziz, N, Olmstead, R, Irwin, MR, Cole, SW. Inflammatory responses to psychological stress in fatigued breast cancer survivors: Relationship to glucocorticoids. Brain Behav Immun 2006
   PubMed Web of Science ®Google Scholar
• Mills, P, Adler, K, Perez, C, Johnson, S, Cohen-Zion, M, Dimsdale, J, et al. Solubel ICAM-1 and fatigue in breast cancer patients in response to chemotherapy. Psychosomatic Medicine 2003;65, (Abstract)
   Google Scholar
• Bower JE, Ganz PA, Aziz N. Altered cortisol response to psychologic stress in breast cancer survivors with persistent fatigue. Psychosom Med 2005; 67: 277–80
   PubMed Web of Science ®Google Scholar
• Bower JE. Prevalence and causes of fatigue after cancer treatment: The next generation of research. J Clin Oncol 2005; 23: 8280–2
   PubMed Web of Science ®Google Scholar
• Mock V. Evidence-based treatment for cancer-related fatigue. J Natl Cancer Inst Monographs 2004; 32: 112–8
   PubMedGoogle Scholar
• Courneya KS, Mackey JR, Bell GJ, Jones LW, Field CJ, Fairey AS. Randomized controlled trial of exercise training in postmenopausal breast cancer survivors: Cardiopulmonary and quality of life outcomes. J Clin Oncol 2003; 21: 1660–8
   PubMed Web of Science ®Google Scholar
• Helgeson VS, Cohen S, Schulz R, Yasko J. Education and peer discussion group interventions and adjustment to breast cancer. Arch Gen Psychiatry 1999; 56: 340–7
   PubMed Web of Science ®Google Scholar
• Helgeson VS, Cohen S, Schulz R, Yasko J. Long-term effects of educational and peer discussion group interventions on adjustment to breast cancer. Health Psychol 2001; 20: 387–92
   PubMed Web of Science ®Google Scholar
• Fawzy FI, Cousins N, Fawzy NW, Kemeny ME, Elashoff R, Morton D. A structured psychiatric intervention for cancer patients. I. Changes over time in methods of coping and affective disturbance. Arch Gen Psychiatry 1990; 47: 720–5
   PubMed Web of Science ®Google Scholar
• Spiegel D, Bloom JR, Yalom I. Group support for patients with metastatic cancer. A randomized outcome study. Arch Gen Psychiatry 1981; 38: 527–33
   PubMed Web of Science ®Google Scholar
• Given B, Given CW, McCorkle R, Kozachik S, Cimprich B, Rahbar MH, et al. Pain and fatigue management: Results of a nursing randomized clinical trial. Oncol Nurs Forum 2002; 29: 949–56
   PubMedGoogle Scholar
• Jacobsen PB, Meade CD, Stein KD, Chirikos TN, Small BJ, Ruckdeschel JC. Efficacy and costs of two forms of stress management training for cancer patients undergoing chemotherapy. J Clin Oncol 2002; 20: 2851–62
   PubMed Web of Science ®Google Scholar
• Stanton AL, Ganz PA, Kwan L, Meyerowitz BE, Bower JE, Krupnick JL, et al. Outcomes from the moving beyond cancer psychoeducational, randomized, controlled trial with breast cancer patients. J Clin Oncol 2005; 23: 6009–18
   PubMed Web of Science ®Google Scholar